BOSTON, Mass. and AUSTIN, Texas, July 07, 2026 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated central nervous system (CNS) precision neuroscience biopharmaceutical company, and Remagine Labs, Inc., a developer of electronically controlled transdermal drug delivery systems, today announced a research collaboration and license agreement to develop an iontophoretic transdermal patch for the […]
January 2025 – The International Essential Tremor Foundation (IETF) is boosting its support for young people with essential tremor (ET). At its recent meeting, the IETF Board of Directors approved a four-fold increase in financial assistance through its Catherine Rice Scholarship Program.
BOSTON, MA, UNITED STATES, December 30, 2024 — In a remarkable acknowledgment of technological advancement and human-centered innovation, GyroGear™ is proud to announce that the GyroGlove™ hand stabilizer has been recognized as one of TIME’s Best Innovations of 2024.
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Encora Therapeutics is pleased to announce the successful completion of the ULTRE (Upper Limb Tremor Reduction in Essential Tremor) clinical trial. This study evaluated the safety, tolerability, and efficacy of Encora’s wrist-worn stimulation device for patients with essential tremor (ET), a tremor disorder affecting the upper limbs of an estimated 7.6 million Americans. […]
CAMBRIDGE Mass. – July 24, 2024 – Sage Therapeutics, Inc. (NASDAQ: Sage) and Biogen Inc. (NASDAQ: BIIB) announced topline results from the Phase 2 KINETIC 2 dose-range study of the oral investigational drug SAGE-324 (BIIB124) as a potential treatment in essential tremor (ET). The KINETIC 2 Study did not demonstrate a statistically significant dose-response relationship […]
(MINNEAPOLIS, Minn.) January 29, 2024 – Fasikl, a Minnesota-based neuro-AI company, announces the completion of two prospective studies for their Felix™ NeuroAI™ Wristband, a wearable technology specifically engineered to offer all-day relief from tremors for adults suffering from a condition known as essential tremor. Results from the studies simultaneously conducted in the United States (US) and […]
BOSTON and SHANGHAI, Jan. 05, 2024 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced an exclusive collaboration and license agreement with Tenacia Biotechnology (Shanghai) Company, Ltd., a China-based clinical-stage biopharmaceutical […]
MIAMI, Oct. 16, 2023 /PRNewswire/ — Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care, today announced that it has been awarded the 2023 BioFlorida David J. Gury Company of the Year Award for distinguished achievement in focused ultrasound technology and contributions to Florida’s life sciences industry. The award was presented at BioFlorida’s 26th Annual […]
BOSTON, Oct. 02, 2023 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today provided an update on its clinical portfolio at the company’s R&D Day. Praxis’ leaders were joined by two esteemed […]
June 14, 2023 – Cala announced today that it launched its next-generation Cala kIQ system, a wearable device that delivers therapy for neurological disorders. The San Mateo, California-based company develops the Cala Trio device for transcutaneous afferent patterned stimulation (TAPS) therapy. Cala designed the Trio device for treating tremor. Its kIQ system delivers therapy for action […]